Antman EM,Anbe DT,Armstrong PW,Bates ER,Green LA,Hand M .2004 .ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. Circulation, 110(5) : 588-636.
Niccoli G,Scalone G,Lerman A,Crea F .2009 .Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J, 30(24) : 2886-93.
Topol EJ,Moliterno DJ,Herrmann HC,Powers ER,Grines CL,Cohen DJ .2001 .Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med, 344(25) : 1888-94.
.1994 .Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med, 330(14) : 956-61.
.1998 .Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med, 339(7) : 436-43.
De Luca G,Suryapranata H,Stone GW,Antoniucci D,Tcheng JE,Neumann FJ .2009 .Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA, 301(13) : 1365-73.
.2001 .Comparison of abciximab and tirofiban for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med, 344(25) : 1888-94.
Stone GW,Grines CL,Cox DA,Garcia E,Tcheng JE,Griffin JJ .2001 .Comparison of angioplasty with stenting with and without abciximab for acute myocardial infarction. N Engl J Med, 344(7) : 493-501.
Henriques JP,Zijlstra F,Hof AW,de Boer MJ,Dambrink JH,Gosselink AT .2003 .Angiographic no-reflow phenomenon in acute myocardial infarction: the TIMI frame count and myocardial blush grade identify different forms of distal embolization. J Am Coll Cardiol, 42(11) : 1772-7.
Zeymer U,Vogt A,Zahn R,Weber M,Tebbe U,Gottwik M .2003 .Predictors of no reflow after primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction. Int J Cardiol, 90(1) : 119-25.
Gershlick AH,More R,Banning AP,Dissanayake A,Rickards A .2005 .A randomized, placebo-controlled trial of rescue angioplasty after failed thrombolysis: The Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) trial. J Am Coll Cardiol, 46(6) : 827-36.
Jolly SS,Yusuf S,Cairns J,Meeks B,Pogue J,Rokoss MJ .2009 .Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomized, parallel group, multicentre trial. Lancet, 377(9775) : 1409-20.
Tamhane UU,Gurm HS .2008 .The chimeric monoclonal antibody abciximab: a systematic review of its safety in contemporary practice. Expert Opin Drug Saf, 7(6) : 809-19.
Dunn CJ,Foster RH .1999 .Abciximab: a pharmacoeconomic review of its use in percutaneous coronary revascularisation. Pharmacoeconomics, 16 : 711-41.
'Connor O,Platek CM,McCullough AE,PA AE .2003 .Safety profile of GP IIb/IIIa inhibitors: a review. Circulation, 107(23) : 2924-9.
Stone GW,McLaurin BT,Cox DA .2004 .The safety and efficacy of GP IIb/IIIa inhibitors: a comprehensive review. N Engl J Med, 350(24) : 2470-9.